TREATMENT OF THE MYELODYSPLASTIC SYNDROME

被引:2
|
作者
AUL, C
HEYLL, A
GATTERMANN, N
SCHNEIDER, W
机构
关键词
D O I
10.1055/s-2008-1068050
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:309 / 313
页数:5
相关论文
共 50 条
  • [21] Treatment of myelodysplastic syndrome (MDS) with amifostine (AMF).
    Jarchum, G
    Ryser, R
    Bove, V
    Garcia, J
    Minoldo, D
    Heller, V
    Gallo, M
    Lavarda, M
    Ruibal, S
    Alonso, M
    Palazzo, E
    [J]. BLOOD, 1997, 90 (10) : 4041 - 4041
  • [22] Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome
    Komrokji, Rami S.
    Al Ali, Najla H.
    Alrawi, E.
    Padron, Eric
    Perkins, Janelle
    Field, Teresa
    Lancet, Jeffrey E.
    List, Alan F.
    [J]. BLOOD, 2011, 118 (21) : 745 - 746
  • [23] Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome
    Chan, G
    DiVenuti, G
    Miller, K
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (03) : 166 - 171
  • [24] Treatment of perianal infection in a patient with myelodysplastic syndrome
    Zhong, Shijiang
    You, Ting
    Wang, Wei
    Li, You
    [J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (08) : 3541 - 3542
  • [25] CLINICAL COURSE AND TREATMENT OF MYELODYSPLASTIC SYNDROME (MDS)
    DONHUIJSENANT, R
    FUCHS, R
    SCHROEDER, M
    WESTERHAUSEN, M
    [J]. BLUT, 1988, 56 (06): : C15 - C15
  • [26] Treatment of myelodysplastic syndrome (MDS) with amifostine.
    deCastro, CM
    Gockerman, JP
    Moore, JO
    Hartung, C
    Misuraca, J
    [J]. BLOOD, 1998, 92 (10) : 251B - 251B
  • [27] Treatment of Higher-Risk Myelodysplastic Syndrome
    Garcia-Manero, Guillermo
    [J]. SEMINARS IN ONCOLOGY, 2011, 38 (05) : 673 - 681
  • [28] Haemopoietic growth factors in the treatment of myelodysplastic syndrome
    Fra, Gian Paolo
    Avanzi, Gian Carlo
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (11) : 1557 - 1568
  • [29] Is lenalidomide a new standard treatment for myelodysplastic syndrome?
    Kuendgen, Andrea
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (07): : 396 - 397
  • [30] Is lenalidomide a new standard treatment for myelodysplastic syndrome?
    Andrea Kuendgen
    [J]. Nature Clinical Practice Oncology, 2007, 4 : 396 - 397